4
Changes in Ownership
Akebia Therapeutics, Inc. Filed Acc 0001562180-16-003207
SVP, Chief Business Officer sold 1,401 shares at $8.95 ($12,546)
From the SEC's structured data for this filing
Trades in this filing
Dahan Michel · SVP, Chief Business Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-10-01 | Sale : show line 1 in the form | −1,401 | $8.95 | $12,546 | 72,153 | D |
| Open-market sales · 1,401 sh · avg $8.95 · $12,546 | ||||||
Loading xslF345X03/primarydocument.xml…